Transdermal buspirone patch data

Preliminary analysis of Phase III trials showed that transdermal buspirone reduced baseline anxiety

Read the full 137 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE